Cecily L. Wait

2.0k total citations · 1 hit paper
9 papers, 1.5k citations indexed

About

Cecily L. Wait is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Cecily L. Wait has authored 9 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 3 papers in Genetics and 2 papers in Surgery. Recurrent topics in Cecily L. Wait's work include Chronic Lymphocytic Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Mast cells and histamine (2 papers). Cecily L. Wait is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Mast cells and histamine (2 papers). Cecily L. Wait collaborates with scholars based in United States. Cecily L. Wait's co-authors include Michael C. Heinrich, Diana Griffith, Brian Druker, Amy J. Zigler, Laura McGreevey, Christopher L. Corless, Oscar W. Cummings, Jonathan A. Fletcher, Ajia Town and Kathleen Kemmer and has published in prestigious journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and Cancer.

In The Last Decade

Cecily L. Wait

9 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor

2000 831 citations Michael C. Heinrich, Diana Griffith et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cecily L. Wait United States	8	563	455	437	347	340	9	1.5k
Sheng Xiao United States	9	277 0.5×	642 1.4×	794 1.8×	404 1.2×	396 1.2×	24	1.8k
Hiroyuki Sugahara Japan	16	571 1.0×	145 0.3×	186 0.4×	681 2.0×	79 0.2×	36	1.9k
K. Henry United Kingdom	17	86 0.2×	100 0.2×	212 0.5×	267 0.8×	201 0.6×	42	1.3k
Eugenia Haralambieva Germany	24	287 0.5×	131 0.3×	168 0.4×	637 1.8×	103 0.3×	52	2.1k
P.M. Kluin Netherlands	26	165 0.3×	83 0.2×	175 0.4×	490 1.4×	139 0.4×	37	2.2k
VC Broudy United States	24	1.6k 2.9×	54 0.1×	289 0.7×	733 2.1×	116 0.3×	42	2.7k
Kerrington D. Smith United States	23	358 0.6×	37 0.1×	619 1.4×	681 2.0×	604 1.8×	50	2.2k
Claudia Le United States	5	60 0.1×	395 0.9×	442 1.0×	386 1.1×	148 0.4×	5	1.1k
Andrea L. Dewar Australia	10	426 0.8×	39 0.1×	95 0.2×	161 0.5×	50 0.1×	11	796
A Katz France	19	1.3k 2.3×	25 0.1×	216 0.5×	516 1.5×	110 0.3×	31	1.9k

Countries citing papers authored by Cecily L. Wait

Since Specialization

Citations

This map shows the geographic impact of Cecily L. Wait's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecily L. Wait with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecily L. Wait more than expected).

Fields of papers citing papers by Cecily L. Wait

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecily L. Wait. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecily L. Wait. The network helps show where Cecily L. Wait may publish in the future.

Co-authorship network of co-authors of Cecily L. Wait

This figure shows the co-authorship network connecting the top 25 collaborators of Cecily L. Wait. A scholar is included among the top collaborators of Cecily L. Wait based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecily L. Wait. Cecily L. Wait is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Kemmer, Kathleen, Christopher L. Corless, Jonathan A. Fletcher, et al.. (2004). KIT Mutations Are Common in Testicular Seminomas. American Journal Of Pathology. 164(1). 305–313. 253 indexed citations

2.

Moses, Ashlee V., Michael A. Jarvis, Camilo Raggo, et al.. (2002). A Functional Genomics Approach to Kaposi's Sarcoma. Annals of the New York Academy of Sciences. 975(1). 180–191. 21 indexed citations

3.

Moses, Ashlee V., Michael A. Jarvis, Camilo Raggo, et al.. (2002). Kaposi's Sarcoma-Associated Herpesvirus-Induced Upregulation of the c-kitProto-Oncogene, as Identified by Gene Expression Profiling, Is Essential for the Transformation of Endothelial Cells. Journal of Virology. 76(16). 8383–8399. 121 indexed citations

4.

Yee, Kevin, A O’Farrell, Beverly D. Smolich, et al.. (2002). SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase. Blood. 100(8). 2941–2949. 140 indexed citations

5.

Zeidler, Adina, Leslie J. Raffel, Gertrude Costin, et al.. (2001). Autoantibodies and Human Leucocyte Antigen Class II in First-Degree Family Members of Mexican-American Type 1 Diabetic Patients. The Journal of Clinical Endocrinology & Metabolism. 86(10). 4957–4962. 6 indexed citations

6.

Rader, Anne E., Anne C. Avery, Cecily L. Wait, et al.. (2001). Fine-needle aspiration biopsy diagnosis of gastrointestinal stromal tumors using morphology, immunocytochemistry, and mutational analysis of c-kit. Cancer. 93(4). 269–275. 92 indexed citations

7.

Lu, Li, Mu‐Shui Dai, Yue Ge, et al.. (2000). Co-transduction of cDNAs for c-kit and Steel Factor into Single CD34 ⁺ Cord Blood Cells Further Enhances the Growth of Erythroid and Multipotential Progenitors. Journal of Hematotherapy & Stem Cell Research. 9(6). 813–825. 7 indexed citations

8.

Heinrich, Michael C., et al.. (2000). Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood. 96(3). 925–932. 65 indexed citations

9.

Heinrich, Michael C., et al.. (2000). Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood. 96(3). 925–932. 831 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact